Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance.
acute myocardial infarction
feature tracking
infarct size
left ventricular recovery
myocardial area-at-risk
myocardial salvage index
strain
Journal
Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414
Informations de publication
Date de publication:
11 Jul 2023
11 Jul 2023
Historique:
received:
03
05
2023
revised:
31
05
2023
accepted:
11
06
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Left ventricular global longitudinal strain (LV GLS) is a superior predictor of adverse cardiac events in patients with myocardial infarction and heart failure. We investigated the ability of morphological features of infarcted myocardium to detect acute left ventricular (LV) dysfunction and predict LV functional recovery after three months in patients with acute ST-segment elevation myocardial infarction (STEMI). Sixty-six STEMI patients were included in the C-reactive protein (CRP) apheresis in Acute Myocardial Infarction Study (CAMI-1). LV ejection fraction (LVEF), LV GLS, LV global circumferential strain (LV GCS), infarct size (IS), area-at-risk (AAR), and myocardial salvage index (MSI) were assessed by CMR 5 ± 3 days (baseline) and 12 ± 2 weeks after (follow-up) the diagnosis of first acute STEMI. Significant changes in myocardial injury parameters were identified after 12 weeks of STEMI diagnosis. IS decreased from 23.59 ± 11.69% at baseline to 18.29 ± 8.32% at follow-up ( The CMR tissue characteristics of myocardial injury correlate with the magnitude of LV dysfunction during the acute stage of STEMI. AAR predicts improvement in LVEF and LV GLS, while MSI is a sensitive marker of LV GCS recovery at three months follow-up after STEMI.
Sections du résumé
BACKGROUND
BACKGROUND
Left ventricular global longitudinal strain (LV GLS) is a superior predictor of adverse cardiac events in patients with myocardial infarction and heart failure. We investigated the ability of morphological features of infarcted myocardium to detect acute left ventricular (LV) dysfunction and predict LV functional recovery after three months in patients with acute ST-segment elevation myocardial infarction (STEMI).
METHODS
METHODS
Sixty-six STEMI patients were included in the C-reactive protein (CRP) apheresis in Acute Myocardial Infarction Study (CAMI-1). LV ejection fraction (LVEF), LV GLS, LV global circumferential strain (LV GCS), infarct size (IS), area-at-risk (AAR), and myocardial salvage index (MSI) were assessed by CMR 5 ± 3 days (baseline) and 12 ± 2 weeks after (follow-up) the diagnosis of first acute STEMI.
RESULTS
RESULTS
Significant changes in myocardial injury parameters were identified after 12 weeks of STEMI diagnosis. IS decreased from 23.59 ± 11.69% at baseline to 18.29 ± 8.32% at follow-up (
CONCLUSION
CONCLUSIONS
The CMR tissue characteristics of myocardial injury correlate with the magnitude of LV dysfunction during the acute stage of STEMI. AAR predicts improvement in LVEF and LV GLS, while MSI is a sensitive marker of LV GCS recovery at three months follow-up after STEMI.
Identifiants
pubmed: 37504550
pii: jcdd10070294
doi: 10.3390/jcdd10070294
pmc: PMC10380630
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Circ Cardiovasc Imaging. 2020 Dec;13(12):e011491
pubmed: 33297764
Eur Heart J. 2005 Aug;26(15):1461-74
pubmed: 15831557
Eur Heart J Cardiovasc Imaging. 2016 Jan;17(1):76-84
pubmed: 25983233
N Engl J Med. 2000 Nov 16;343(20):1445-53
pubmed: 11078769
JACC Cardiovasc Imaging. 2018 Oct;11(10):1433-1444
pubmed: 29454776
JACC Cardiovasc Imaging. 2015 Dec;8(12):1379-1389
pubmed: 26699107
Lancet. 2021 Mar 20;397(10279):1085-1094
pubmed: 33711294
Circ Cardiovasc Interv. 2018 Sep;11(9):e006842
pubmed: 30354595
Nat Med. 2023 May;29(5):1201-1210
pubmed: 37169863
J Am Coll Cardiol. 2019 Jul 16;74(2):238-256
pubmed: 31296297
N Engl J Med. 2004 Dec 9;351(24):2481-8
pubmed: 15590950
Circ Cardiovasc Interv. 2021 Feb;14(2):e009879
pubmed: 33440999
Circ Cardiovasc Imaging. 2011 May;4(3):228-36
pubmed: 21447711
Heart. 2011 Dec;97(24):2038-45
pubmed: 21990384
Circulation. 2018 May 1;137(18):1949-1964
pubmed: 29712696
Eur Heart J. 2009 Mar;30(6):689-98
pubmed: 19155249
Clin Res Cardiol. 2021 Jan;110(1):61-71
pubmed: 32296969
J Cardiovasc Magn Reson. 2020 Mar 12;22(1):19
pubmed: 32160925
J Am Coll Cardiol. 2010 Jun 1;55(22):2470-9
pubmed: 20510214
Int J Cardiovasc Imaging. 2002 Feb;18(1):539-42
pubmed: 12135124
J Cardiovasc Magn Reson. 2015 Jul 28;17:63
pubmed: 26215273
Eur Heart J Cardiovasc Imaging. 2020 Sep 30;:
pubmed: 32995886
Front Cardiovasc Med. 2021 Mar 10;8:591714
pubmed: 33778017
Am Heart J. 2020 May;223:87-97
pubmed: 32203684
PLoS One. 2021 Jan 28;16(1):e0245684
pubmed: 33507957
Diabetes Res Clin Pract. 2021 Aug;178:108959
pubmed: 34280467
J Am Coll Cardiol. 2016 Apr 12;67(14):1674-83
pubmed: 27056772
Eur Radiol. 2020 Jan;30(1):600-608
pubmed: 31350585
N Engl J Med. 2009 Oct 8;361(15):1427-36
pubmed: 19812399
J Cardiovasc Magn Reson. 2017 Feb 17;19(1):24
pubmed: 28209163
J Cardiovasc Magn Reson. 2014 Oct 07;16:85
pubmed: 25315701
Trials. 2014 Jun 25;15:249
pubmed: 24962156
Circulation. 1990 Apr;81(4):1161-72
pubmed: 2138525
Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082
pubmed: 29198432
J Cardiovasc Magn Reson. 2020 Jun 11;22(1):44
pubmed: 32522198
Eur Radiol. 2018 Mar;28(3):1257-1266
pubmed: 28875228
ESC Heart Fail. 2020 Apr;7(2):474-481
pubmed: 32059084
JACC Cardiovasc Imaging. 2010 Jan;3(1):45-51
pubmed: 20129530
J Am Coll Cardiol. 2010 Jun 1;55(22):2459-69
pubmed: 20510213
Circ Cardiovasc Imaging. 2017 Jul;10(7):
pubmed: 28674085
Eur Heart J. 2005 Apr;26(8):762-9
pubmed: 15778204
MAGMA. 2018 Feb;31(1):75-85
pubmed: 28620752
J Am Coll Cardiol. 2003 Aug 6;42(3):513-8
pubmed: 12906982
Front Immunol. 2021 Feb 10;12:630430
pubmed: 33679775
Circulation. 2002 Jul 9;106(2):e6; author reply e6
pubmed: 12105174